MedTrace Logo

Mycobacterium Avium Intracellulare Complex (MAC) Study

NCT00826423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2012-07-30

No results posted yet for this study

Summary

This study is short course (3 month) multiple drug antibiotic therapy. The purpose of this research study is to evaluate the clinical and radiology response to assess whether drug resistance develops and assess quality of life measures with MAC disease.

Conditions

  • Mycobacterium Avium Intracellulare Complex (MAC)

Sponsors & Collaborators

Principal Investigators

  • Jack P Leventhal, MD · Mayo Clinic Assistant Professor of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-06-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00826423 on ClinicalTrials.gov